Prebiotic Effects of a Polyphenol-rich Food Product
1 other identifier
interventional
25
1 country
1
Brief Summary
The specific aim for this project will be to investigate a cranberry beverage as a means to restore balance in terms of the relative proportions of the various bacteria that inhabit the large intestine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2018
CompletedFirst Posted
Study publicly available on registry
September 6, 2018
CompletedStudy Start
First participant enrolled
October 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 24, 2019
CompletedMarch 2, 2023
February 1, 2023
5 months
September 3, 2018
February 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Fecal microbial community composition and structure
We will investigate if specific bacterial taxa are stimulated by daily consumption of a cranberry beverage.
Changes in the fecal microbiota will be measured after a 20-day intervention period
Study Arms (2)
Cranberry beverage
EXPERIMENTALPlacebo beverage
PLACEBO COMPARATORInterventions
During the intervention period, research participants will consume a cranberry beverage daily.
During the intervention period, research participants will consume a placebo beverage daily.
Eligibility Criteria
You may qualify if:
- BMI 27-35 kg/m2
- High waist circumference (men \>102 cm and women \>88 cm)
You may not qualify if:
- Cigarette smoking
- Regular intensive exercise
- Pregnancy or lactation
- Chronic diarrhea, constipation, or other gastrointestinal complaint
- Diabetes mellitus, autoimmune disease, or other chronic disease known to alter the gut microbiota
- Use of medications that affect inflammation or the gut microbiota
- Use of prebiotics, probiotics, synbiotics, vitamins, or other dietary supplements known to affect the gut microbiota
- Aversion to cranberries
- Food allergies
- Lactose intolerance
- Vegetarianism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nutrition and Wellness Research Center
Ames, Iowa, 50011, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 3, 2018
First Posted
September 6, 2018
Study Start
October 9, 2018
Primary Completion
February 24, 2019
Study Completion
February 24, 2019
Last Updated
March 2, 2023
Record last verified: 2023-02